Abstract:Spontaneous previable rupture of membranes complicates approximately 0.4-0.7% of pregnancies and is associated with severe maternal and neonatal morbidity and mortality. Intra-amniotic inflammation is present in up to 94.4% of cases, most often caused by a bacterial infection. In comparison, the effectiveness of antibiotic therapy in its eradication reaches less than 17%. Inflammatory activity in the amniotic cavity disrupts the physiological development of the fetus with an increase in maternal, fetal, and neonatal inflammatory morbidity through the development of fetal inflammatory response syndrome, maternal chorioamnionitis, and neonatal sepsis. Amniopatch is an invasive therapeutic technique based on intra-amniotic administration of maternal hemoderivates in the form of thromboconcentrate and plasma cryoprecipitate to provide the temporary closure of the fetal membranes defect and secondary restitution of normohydramnios with correction of pressure-volume ratios. The supposed basis of this physical-mechanical action is the aggregation of coagulant components of amniopatch in the area of the defect with the formation of a valve cap. The background for the formulation of the hypothesis on the potential anti-infectious and anti-inflammatory action of non-coagulant components of amniopatch involved: i) clinical-academic and publishing outputs of the authors based on their many years' experience with amniopatch application in the treatment of spontaneous previable rupture of membranes (2008-2019), ii) the documented absence of clinically manifested chorioamnionitis in patients treated this way with a simultaneously reduced incidence of neonatal respiratory distress syndrome compared to expectant management (tocolysis, corticotherapy, antibiotic therapy). The non-coagulant components of plasma cryoprecipitate include mainly naturally occurring isohemagglutinins, albumin, and soluble plasma fibrinogen. Although these components of the amniopatch have not been attributed a significant therapeutic role, the authors assume that due to their opsonizing and aggregative properties, they can significantly participate in optimizing the intrauterine environment through the reduction in bacterial and cytokine charge in the amniotic fluid. The authors think these facts constitute a vital stimulus to future research-academic activity and, at the same time, an idea for reconsidering the therapeutic role of amniopatch as a tool for improving perinatal results of spontaneous previable ruptures of membranes.

Lyophilised amniotic membrane patches are a safe and effective treatment for rhegmatogenous lesions in combined tractional and rhegmatogenous retinal detachment: a prospective interventional study

A Novel Technique Using Lyophilized Amniotic Membrane Patch (LAMPatch) as Primary Procedure in Patients with Myopic Traction Maculopathy with Macular Detachment

Primary Silicone Oil Tamponade and Internal Limiting Membrane Peeling for Retinal Detachment Due to Macular Hole in Highly Myopic Eyes with Chorioretinal Atrophy

Biocompatibility and Efficacy of a Linearly Cross-Linked Sodium Hyaluronic Acid Hydrogel as a Retinal Patch in Rhegmatogenous Retinal Detachment Repairment

Human Amniotic Membrane: A Seal for Complex Retinal Detachments

PRETREATED LHAM GRAFT COVERING FOR RETINAL DETACHMENT WITH POSTERIOR RETINAL BREAKS ABOVE CHORIORETINAL ATROPHY IN PATHOLOGIC MYOPIA

Safety and efficacy of human amniotic membrane plug transplantation in cases of macular hole. A scoping review

Direct Laser Photocoagulation of the Retinal Pigment Epithelium: A Novel Method to Seal Retinal Breaks during Pars Plana Vitrectomy for Retinal Detachment

Application progress of human amniotic membrane in vitreoretinopathy: a literature review

Contraction of a Giant Epiretinal Human Amniotic Membrane Patch Used to Manage a Highly Myopic Retinal Detachment Associated With Multiple Breaks

Effects of a human amniotic membrane extract on ARPE-19 cells

Internal limiting membrane peeling in rhegmatogenous retinal detachment: A meta-analysis

Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications

Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction

The no-retina-touch technique: vitrectomy and platelet-rich plasma in the treatment of lamellar macular hole. New insights into pathogenesis

Temporary Amniotic Membrane Patch for the Treatment of Primary Pterygium: Mechanisms of Reducing the Recurrence Rate

Anti-infectious and anti-inflammatory effect of amniopatch in the treatment of spontaneous previable rupture of membranes

Amniotic Membrane Implantation in Trabeculectomy and Non-Penetrating Deep Sclerectomy

Amniotic membrane graft for persistent macular hole following retinal detachment repair in Knobloch syndrome

Treatment and prevention of ocular motility restrictions with amniotic membrane transplantation

Clinical Study the Effects of Early Vitrectumy Combined with Triameinolone Acetunide Injection in Vitreous Cavity on Rupture of the Eyeballs